美股市场个股详情
INCY 因塞特
- 80.480
- -0.100-0.12%
收盘价 11/13 16:00 (美东)
- 80.480
- 0.0000.00%
盘后 20:01 (美东)
155.04亿总市值894.22市盈率TTM
81.700最高价80.370最低价157.32万股成交量80.800今开80.580昨收1.27亿成交额0.98%换手率30.37市盈率(静)1.93亿总股本83.95052周最高4.89市净率128.94亿流通值50.35052周最低--股息TTM1.60亿流通股153.150历史最高--股息率TTM1.65%振幅1.850历史最低80.862平均价1股每手
关于因塞特公司
因塞特医疗公司是一家生物制药公司，从事专利疗法的发现、开发和商业化。
公司介绍
公司代码INCY
公司名称因塞特
上市日期1993/11/04
发行价格7.50
成立日期1991
CEOMr. Herve Hoppenot
所属市场纳斯达克
员工数量2524
年结日12-31
公司地址1801 Augustine Cut-Off
城市Wilmington
省份特拉华州
国家美国
邮编19803
电话1-302-498-6700
董事高管
- 姓名
- 职务
- 年薪
- Herve Hoppenot
- Chairman of the Board, President and Chief Executive Officer
- 1665.95万
- Christiana Stamoulis, M.B.A.
- Executive Vice President and Chief Financial Officer
- 508.45万
- Thomas Tray
- Vice President and Chief Accounting Officer
- --
- Dr. Steven H. Stein, M.D.
- Executive Vice President and Chief Medical Officer
- 562.81万
- Barry P. Flannelly, Pharm.D.
- Executive Vice President and General Manager, North America
- 409.19万
- Jonathan Elliott Dickinson
- Executive Vice President and General Manager, Europe
- --
- Paula J. Swain
- Executive Vice President, Human Resources
- --
- Sheila A Denton
- Executive Vice President, General Counsel and Corporate Secretary
- --
- Michael James Morrissey
- Executive Vice President and Head of Global Technical Operations
- --
- Vijay K. Iyengar
- Executive Vice President, Global Strategy and Corporate Development
- --
- Dr. Pablo J. Cagnoni, M.D.
- President and Head of Research and Development
- 1583.29万
- Dr. Katherine A. High, M.D.
- Independent Director
- 45.48万
- Dr. Edmund P. Harrigan, M.D.
- Independent Director
- 48.23万
- Paul J. Clancy
- Independent Director
- 47.98万
- Dr. Jacqualyn A. Fouse, PhD
- Independent Director
- 46.63万
- Julian C. Baker
- Lead Independent Director
- 51.28万
- Dr. Susanne Schaffert, PhD
- Independent Director
- 44.48万
- Dr. Otis W. Brawley,M.D.
- Independent Director
- 45.48万
- Jean-Jacques Bienaime
- Independent Director
- 47.88万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据
